Evommune, Inc.(EVMN:US)
Market Cap$186.21M
Key Metrics
Price$5.17
Revenue (TTM)-
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-
EBITDA (TTM)-
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$48.32M
Total Assets$322.46M
Net Assets$304.56M
Total Debt$8.55M
Key Metrics
Price$5.17
Revenue (TTM)-
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-
EBITDA (TTM)-
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$48.32M
Total Assets$322.46M
Net Assets$304.56M
Total Debt$8.55M
Financials
| Name | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Dec 31, 2024 | Sep 30, 2024 |
|---|---|---|---|---|---|
Revenue | $0 | $0 | $10M | $0 | $0 |
Cost of Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
| $23.95M | $29.72M | $23.33M | $21.45M | $16.52M | |
| Research and Development | $17.32M | $20.4M | $19.64M | $17.83M | $13.29M |
| Selling, General, and Administrative | $6.64M | $9.31M | $3.69M | $3.62M | $3.23M |
| Other Operating Expenses | - | - | - | - | - |
Operating Income | -$23.95M | -$29.72M | -$13.33M | -$21.45M | -$16.52M |
| $2.28M | $1.44M | $853K | $728K | $601K | |
| Non-Operating Interest Income | $2.28M | $1.44M | $862K | $727K | $618K |
| Non-Operating Interest Expense | - | - | - | - | - |
| Other Income/Expense | -$4K | $0 | -$9K | $1K | -$17K |
Income Before Tax | -$21.67M | -$28.27M | -$12.48M | -$20.73M | -$15.92M |
Income Tax | - | - | - | - | - |
Net Income | -$21.67M | -$28.27M | -$12.48M | -$20.73M | -$15.92M |
Minority Interests | - | - | - | - | - |
Preferred Stock Dividends | - | - | - | - | - |
Net Income to Common | -$21.67M | -$28.27M | -$12.48M | -$20.73M | -$15.92M |
Shares Outstanding (Basic) | 33.67M | 19.78M | 30.08M | - | 16M |
Shares Outstanding (Diluted) | 33.67M | 19.78M | 30.08M | - | 16M |
EPS (Basic) | -$0.64 | -$1.43 | -$0.41 | - | -$0.99 |
EPS (Diluted) | -$0.64 | -$1.43 | -$0.41 | - | -$0.99 |
EBIT | -$23.95M | -$29.72M | -$13.33M | -$21.45M | -$16.52M |
EBITDA | -$23.61M | -$29.39M | -$13.02M | -$21.09M | -$16.19M |